Biphasic actions of prostaglandin E2 on the renal afferent arteriole: Role of EP3 and EP4 receptors

Circulation Research

Volumn 86, Issue 6, 2000, Pages 663-670

  Tang, Lilong ^a   Loutzenhiser, Kathy ^a   Loutzenhiser, Rodger ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Angiotensin II; Arterioles; Cyclooxygenase; Microcirculation; Receptors

Indexed keywords

11 DEOXYPROSTAGLANDIN E1; 4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; G PROTEIN COUPLED RECEPTOR; IBUPROFEN; PERTUSSIS TOXIN; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN E2; SULPROSTONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; VASOCONSTRICTION;

EID: 0034737777     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.6.663     Document Type: Article

References (35)

1. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev. 1996;76:425-536.
2. Palmer BF. Renal complications associated with use of nonsteroidal anti-inflammatory agents. J Invest Med. 1995;43:516-533.
3. Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev. 1994;46: 205-229.
4. Edwards RM. Effects of prostaglandins on vasoconstrictor action in isolated renal arterioles. Am J Physiol. 1985;248:F779-F784.
5. Inscho EW, Carmines PK, Navar LG. Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists. Am J Physiol. 1990;259:F157-F163.
6. Breyer MD, Davis L, Jacobson HR, Breyer RM. Differential localization of prostaglandin E receptor subtypes in human kidney. Am J Physiol. 1996;270:F912-F918.
7. Sugimoto Y, Namba T, Shigemoto R, Shigemoto R, Negishi M, Ichikawa A, Narumiya S. Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney. Am J Physiol. 1994;266: F823-F828.
8. Bonilla-Felix M, Jiang W. Expression and localization of prostaglandin EP3 receptor mRNA in the immature rabbit kidney. Am J Physiol. 1996;271:F30-F36.
9. Taniguchi S, Watanabe T, Nakao A, Seki G, Uwatoko S, Kurokawa K. Detection and quantitation of EP3 receptor mRNA along mouse nephron segments by RT-PCR. Am J Physiol. 1994;266:C1452-C1458.
10. Breyer MD, Zhang Y, Guan YF, Hao CM, Hebert RL, Breyer RM. Regulation of renal function by prostaglandin E receptors. Kidney Int Suppl. 1998;67:S88-S94.
11. Loutzenhiser R, Parker M. Hypoxia inhibits myogenic reactivity of renal afferent arterioles by activating ATP-sensitive potassium channels. Circ Res. 1994;74:861-869.
12. Okuda-Ashituka E, Sakamoto K, Ezashi T, Miwa K, Ito S, Hayaishi O. Suppression of prostaglandin E receptor signalling by variant forms of EP1 subtype. J Biol Chem. 1996;271:31255-31261.
13. Boie Y, Stocco R, Sawyer N, Slipetz DM, Ungrin MD, Neuschafer-Rube F, Puschel GP, Metters KM, Abramovitz M. Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Eur J Pharmacol. 1997;340:227-241.
14. Sugimoto Y, Negishi M, Hayashi Y, Namba T, Honda A, Watabe A, Hirata M, Narumiya S, Ichikawa A. Two isoforms of the EP3 receptor with different carboxyl-terminal domains. J Biol Chem. 1993;268: 2712-2718.
15. Neuschafer-Rube F, DeVries C, Hanecke K, Jungermann K, Puschel GP. Molecular cloning and expression of a prostaglandin E2 receptor of the EP3β subtype from rat hepatocytes. FEBS Lett. 1994;351:119-122.
16. Irie A, Sugimoto Y, Namba T, Harazono A, Honda A, Watabe A, Negishi M, Narumiya S, Ichikawa A. Third isoform of the prostaglandin E receptor subtype with different c-terminal tail coupling to both stimulation and inhibition of adenylyl cyclase. Eur J Biochem. 1993;217: 313-318.
17. Abramovitz M, Boie Y, Stocco R. Rattus norvegicus EP4 prostanoid receptor mRNA. 1997. Genebank: g2058686.
18. Tso JY, Sun XH, Kao TH, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acid Res. 1985;13:2485-2502.
19. Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Shugimoto Y, Narumiya S. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol. 1997;122:217-224.
20. Coleman RA, Grix SP, Head SA, Louttit JB, Mallett A, Sheldrick RL. A novel inhibitory prostanoid receptor in piglet saphenous vein. Prostaglandins. 1994;47:151-168.
21. Lydford SJ, McKechnie KCW, Dougall IG. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery. Br J Pharmacol. 1996;117:13-20.
22. 2-sensitive (EP) receptors. Adv Prostaglandin Thromboxane Leukot Res. 1987;17: 467-470.
23. 2 antagonist, and its analogs. J Med Chem. 1996;39:609-613.
24. Morath R, Kline T, Seyberth HW, Nüsing RM. Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney. J Am Soc Nephrol. 1999;10:1851-1860.
25. Lefkowith JB, Needleman P. Arachidonate metabolism in renal injury. Adv Prostaglandin Thromboxane Leukot Res. 1985;13:121-130.
26. Danon A, Zenzer TV, Thomasson DL, Palmier MO, Davis BB. Eicosanoid synthesis by rabbit hydronephrotic cortical interstitial cells in culture. J Pharmacol Exp Ther. 1986;238:95-99.
27. Takenaka T, Forster H. Arginine vasopressin interacts with thromboxane in hydronephrosis. Am J Physiol. 1997;272:F40-F47.
28. Hayashi K, Loutzenhiser R, Epstein M. Direct evidence that thromboxane mimetic U44069 preferentially constricts the afferent arteriole. J Am Soc Nephrol. 1997;1997:25-31.
29. Heller J, Horacek V. Angiotensin II: preferential efferent vasoconstriction? Renal Physiol. 1986;9:357-365.
30. Olsen ME, Hall JE, Montani JP, Cornell JE. Interaction between renal prostaglandins and angiotensin II in controlling glomerular filtration rate in the dog. Clin Sci. 1987;72:429-436.
31. Edwards RM. Segmental effects of norepinephrine and angiotensin II on isolated renal arterioles. Am J Physiol. 1983;244:F526-F534.
32. 2 receptors in the rabbit renal preglomerular microvasculature. Biochem Biophys Acta. 1990;1053:156-161.
33. 2 and its selective receptor analogue sulprostone in rabbit cortical collecting duct. Prostaglandins Leukot Essent Fatty Acids. 1994;51:147-155.
34. Namba T, Sugimoto Y, Negishi M, Irie A, Ushikubi F, Kakizuka A, Ito S, Ichikawa A, Narumiya S. Alternate splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature. 1993;365:166-170.
35. Hayashi K, Epstein M, Loutzenhiser R, Forster H. Impaired myogenic responsiveness of the renal afferent arteriole in streptozotocin-induced diabetic rats: role of eicosanoid derangements. J Am Soc Nephrol. 1992; 2:1578-1586.